These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 21951781)
1. Expression of opioid and anti-opioid receptors in Chinese hamster ovary cells after exposure to dimethyl sulfoxide. Talmont F; Mollereau C; Zajac JM Anal Biochem; 2012 Jan; 420(1):99-100. PubMed ID: 21951781 [TBL] [Abstract][Full Text] [Related]
2. Transient overexpression of kappa and mu opioid receptors using recombinant adenovirus vectors. Zhen Z; Bradel-Tretheway BG; Dewhurst S; Bidlack JM J Neurosci Methods; 2004 Jul; 136(2):133-9. PubMed ID: 15183265 [TBL] [Abstract][Full Text] [Related]
3. Functional characterization of a human receptor for neuropeptide FF and related peptides. Kotani M; Mollereau C; Detheux M; Le Poul E; Brézillon S; Vakili J; Mazarguil H; Vassart G; Zajac JM; Parmentier M Br J Pharmacol; 2001 May; 133(1):138-44. PubMed ID: 11325803 [TBL] [Abstract][Full Text] [Related]
4. Opposite alterations of NPFF1 and NPFF2 neuropeptide FF receptor density in the triple MOR/DOR/KOR-opioid receptor knockout mouse brains. Gouardères C; Kieffer BL; Zajac JM J Chem Neuroanat; 2004 May; 27(2):119-28. PubMed ID: 15121216 [TBL] [Abstract][Full Text] [Related]
5. Modulation by neuropeptide FF of the interaction of mu-opioid (MOP) receptor with G-proteins. Kersanté F; Moulédous L; Zajac JM; Mollereau C Neurochem Int; 2010; 56(6-7):768-73. PubMed ID: 20211672 [TBL] [Abstract][Full Text] [Related]
6. Anoretic effects of neuropeptide FF are mediated via central mu and kappa subtypes of opioid receptors and receptor ligands. Cline MA; Mathews DS Gen Comp Endocrinol; 2008; 159(2-3):125-9. PubMed ID: 18823989 [TBL] [Abstract][Full Text] [Related]
7. Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells. Moulédous L; Merker S; Neasta J; Roux B; Zajac JM; Mollereau C Biochem Biophys Res Commun; 2008 Aug; 373(1):80-4. PubMed ID: 18544342 [TBL] [Abstract][Full Text] [Related]
9. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330 [TBL] [Abstract][Full Text] [Related]
10. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein. Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353 [TBL] [Abstract][Full Text] [Related]
11. Solubilization and functional reconstitution of human neuropeptide FF2 receptors. Talmont F; Mollereau C; Muller I; Zajac JM Anal Biochem; 2010 Mar; 398(2):225-9. PubMed ID: 20018158 [TBL] [Abstract][Full Text] [Related]
12. Effects of interferon-alpha on cloned opioid receptors expressed in Xenopus oocytes. Kobayashi T; Washiyama K; Ikeda K Life Sci; 2004 Dec; 76(4):407-15. PubMed ID: 15530503 [TBL] [Abstract][Full Text] [Related]
13. Promotion of recombinant macrophage colony stimulating factor production by dimethyl sulfoxide addition in Chinese hamster ovary cells. Liu CH; Chen LH J Biosci Bioeng; 2007 Jan; 103(1):45-9. PubMed ID: 17298900 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Raynor K; Kong H; Chen Y; Yasuda K; Yu L; Bell GI; Reisine T Mol Pharmacol; 1994 Feb; 45(2):330-4. PubMed ID: 8114680 [TBL] [Abstract][Full Text] [Related]
15. Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes. Onali P; Dedoni S; Olianas MC J Pharmacol Exp Ther; 2010 Jan; 332(1):255-65. PubMed ID: 19828880 [TBL] [Abstract][Full Text] [Related]
16. Syntheses of immobilized G protein-coupled receptor chromatographic stationary phases: characterization of immobilized mu and kappa opioid receptors. Beigi F; Wainer IW Anal Chem; 2003 Sep; 75(17):4480-5. PubMed ID: 14632053 [TBL] [Abstract][Full Text] [Related]
17. Mu-opioid receptor ligands lack receptor subtype selectivity in the aequorin luminescence-based calcium assay. Fichna J; Staniszewska R; Poels J; Vanden Broeck J; Janecka A Chem Biol Drug Des; 2007 Sep; 70(3):247-53. PubMed ID: 17718719 [TBL] [Abstract][Full Text] [Related]